Global point-of-care diagnostics market predicted to be worth $18.7B by 2020
The point-of-care diagnostics market is continuing to grow - blood testing and monitoring infectious diseases will be much more advanced.
The point-of-care diagnostics market is continuing to grow - blood testing and monitoring infectious diseases will be much more advanced.
Wicab's BrainPort received FDA clearance to help the blind see by using their tastebuds, Gardasil 9 prevents 4 types of cancer in preteens and teenagers.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
San Diego startup Hera Therapeutics is developing a topical antiviral drug that attacks human papillomavirus – and early studies are showing it can successfully combat three strains, including two that cause 70 percent of all cervical cancer. The drug candidate, HTI-1968, blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to the NIAID-sponsored study. The work […]
In honor of National Women’s Health Week, we are highlighting startups focused on women’s health. These companies and these new devices help women stay healthy without draining their wallets. To find more about women’s health and National Women’s Health Week, check out #NWHW and #maternalhealth on Twitter, in addition to the following stories. nVision Medical […]
Cervical cancer is the easiest female cancer to prevent, because there are highly effective vaccines available, and precancerous cells can be detected by Pap tests and treated before they turn into cancer. Yet, in some areas of the world with lower incomes, cervical cancer incidence rates are still high, partially because of limited access to […]